NCT02979119 The European Paediatric Network for Haemophilia Management ( PedNet Registry)
| NCT ID | NCT02979119 |
| Status | Recruiting |
| Phase | — |
| Sponsor | PedNet Haemophilia Research Foundation |
| Condition | Factor VIII Deficiency |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2014-06 |
| Primary Completion | 2039-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2014-06 with a primary completion date of 2039-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rationale: Haemophilia is a rare disease; to improve knowledge international collaboration is needed. Well-defined clinical data will be collected from complete cohorts in order to prevent selection bias. Objective: To collect data on bleeding during neonatal period, endogenous (genetic) and exogenous (treatment-related) determinants of inhibitor development and long term outcome.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with Haemophilia A or B * Factor VIII/ IX activity of \<1 to 25% * Complete records of Factor treatment and bleeds * Treated in one of the participating centres Exclusion Criteria: * Patients referred because of an inhibitor\* * Informed consent not obtained
Contact & Investigator
Gili Kenet, PhD, MD
STUDY DIRECTOR
The National Hemophilia Center Ministry of Health Sheba Medical Center Ramat Gan, Israel
Frequently Asked Questions
Who can join the NCT02979119 clinical trial?
This trial is open to participants of all sexes, studying Factor VIII Deficiency. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02979119 currently recruiting?
Yes, NCT02979119 is actively recruiting participants. Contact the research team at a.hermeling@pednet.eu for enrollment information.
Where is the NCT02979119 trial being conducted?
This trial is being conducted at Graz, Austria, Vienna, Austria, Leuven, Belgium, Montreal, Canada and 11 additional locations.
Who is sponsoring the NCT02979119 clinical trial?
NCT02979119 is sponsored by PedNet Haemophilia Research Foundation. The principal investigator is Gili Kenet, PhD, MD at The National Hemophilia Center Ministry of Health Sheba Medical Center Ramat Gan, Israel. The trial plans to enroll 4,000 participants.